featured
Risk of Exacerbation and Pneumonia With Single Inhaler Triple vs Dual Therapy in COPD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of the American Thoracic Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Exacerbation and Pneumonia With Single Inhaler Triple Versus Dual Therapy in IMPACT
Ann Am Thorac Soc 2020 Oct 27;[EPub Ahead of Print], MT Dransfield, C Crim, GJ Criner, NC Day, DMG Halpin, MK Han, CE Jones, S Kilbride, D LaFon, DA Lipson, DA Lomas, N Martin, FJ Martinez, D Singh, RA Wise, P LangeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.